Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Truong, JK; Bennett, AL; Klindt, C; Donepudi, AC; Malla, SR; Pachura, KJ; Zaufel, A; Moustafa, T; Dawson, PA; Karpen, SJ.
Ileal bile acid transporter inhibition in Cyp2c70 KO mice ameliorates cholestatic liver injury
J LIPID RES. 2022; 63(9): 100261 Doi: 10.1016/j.jlr.2022.100261 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Co-Autor*innen der Med Uni Graz
Moustafa Tarek
Zaufel Alex
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Cyp2c70 is the liver enzyme in rodents responsible for synthesis of the primary 6hydroxylated muricholate bile acid (BA) species. Cyp2c70 KO mice are devoid of protective, hydrophilic muricholic acids, leading to a more human-like BA composition and subsequent cholestatic liver injury. Pharmacological inhibition of the ileal BA transporter (IBAT) has been shown to be therapeutic in cholestatic models. Here, we aimed to determine if IBAT inhibition with SC-435 is protective in Cyp2c70 KO mice. As compared to WT mice, we found male and female Cyp2c70 KO mice exhibited increased levels of serum liver injury markers, and our evaluation of liver histology revealed increased hepatic inflammation, macrophage infiltration, and biliary cell proliferation. We demonstrate serum and histologic markers of liver damage were markedly reduced with SC-435 treatment. Additionally, we show hepatic gene expression in pathways related to immune cell activation and inflammation were significantly upregulated in Cyp2c70 KO mice and reduced to levels indistinguishable from WT with IBAT inhibition. In Cyp2c70 KO mice, the liver BA content was significantly increased, enriched in chenodeoxycholic acid, and more hydrophobic, exhibiting a hydrophobicity index value and red blood cell lysis properties similar to human liver reduced the total hepatic BA levels but did not affect overall hydrophobicity of the liver BAs. These findings suggest that there may be a threshold in the liver for pathological accretion of hydrophobic BAs and reducing hepatic BA accumulation can be sufficient to alleviate liver injury, independent of BA pool hydrophobicity.

Find related publications in this database (Keywords)
Supplementary key words Cytochrome P450
cholesterol 7?-hydroxylase
sterol 12?-hydroxylase
hydrophobicity
detergency
enterohepatic circulation
muricholic acids
chenodeoxycholic acid
biliary cell proliferation
© Med Uni Graz • Impressum